Atlas Trials

A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions

Clinical trial NCT05666518 · RECRUITING

Trial details

NCT number
NCT05666518
Sponsor
Bayer
Status
RECRUITING
Study type
OBSERVATIONAL
Chronic Heart Failure
Start date
2022-08-31
Primary completion
2027-12-31
Enrollment
1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.